Three questions that reveal whether your company controls its AI (www.businessinsider.com)

In a recent analysis, Mahmood Majeed highlights the importance of control over AI systems for companies, particularly in the pharmaceutical and biotechnology sectors. As reliance on major AI providers grows—projected at nearly 60% by 2027—organizations risk vendor lock-in, unpredictable costs, and regulatory challenges. Majeed emphasizes that to maintain autonomy, firms should manage their core data engineering, leverage flexible architectures, and ensure their unique business rules and processes are integral to their AI systems, effectively minimizing dependency on external specialists. Additionally, Majeed discusses the need for clear ownership and accountability regarding the value generated by AI initiatives, which often struggle to show measurable returns on investment. With 70% of technology leaders prioritizing improved collaboration between business and technology teams by 2027, aligning on shared KPIs is essential for translating AI efforts into tangible business success. This strategic approach enables companies to not only harness AI's potential but also to navigate its complexities, ensuring that investments are effectively managed for maximum impact.